A trial of RIT-4237 rotavirus vaccine in 1-month-old infants
- PMID: 2545451
- DOI: 10.1007/BF00441518
A trial of RIT-4237 rotavirus vaccine in 1-month-old infants
Abstract
In a double blind placebo-controlled study rotavirus vaccine RIT 4237 was offered to young infants after the fourth week of life. The vaccine was very well tolerated. Fifty-seven out of 100 vaccine recipients and 10 out of 103 placebo recipients developed rotavirus-IgM-antibodies during the 1 month follow-up period. During a 6 month follow-up, stool samples from 2 out of 12 vaccinees and from 5 out of 12 placebo recipients contained rotavirus.
Similar articles
-
Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine.Lancet. 1984 May 5;1(8384):977-81. doi: 10.1016/s0140-6736(84)92323-7. Lancet. 1984. PMID: 6143964 Clinical Trial.
-
Rhesus Rotavirus candidate vaccine. Clinical trial in children vaccinated between 2 and 5 months of age.Am J Dis Child. 1990 Mar;144(3):285-9. Am J Dis Child. 1990. PMID: 2154925 Clinical Trial.
-
Neonatal rotavirus vaccination with RIT 4237 bovine rotavirus vaccine: a preliminary report.Pediatr Infect Dis J. 1987 Feb;6(2):164-9. doi: 10.1097/00006454-198702000-00005. Pediatr Infect Dis J. 1987. PMID: 3031574 Clinical Trial.
-
The human rotavirus vaccine RIX4414 in infants: a review of safety and tolerability.Pediatr Infect Dis J. 2009 Mar;28(3):225-32. doi: 10.1097/INF.0b013e31819715fa. Pediatr Infect Dis J. 2009. PMID: 19209095 Review.
-
Present status of rotavirus vaccine.Indian Pediatr. 1994 Aug;31(8):957-69. Indian Pediatr. 1994. PMID: 7883349 Review. No abstract available.
Cited by
-
Rotavirus vaccine for preventing diarrhoea.Cochrane Database Syst Rev. 2004;2004(1):CD002848. doi: 10.1002/14651858.CD002848.pub2. Cochrane Database Syst Rev. 2004. PMID: 14973994 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical